Status:
NOT_YET_RECRUITING
Intermittent Fasting Diet Versus Resistive Exercise Program on Insulin Resistance in Obese Women With P.C.O.S
Lead Sponsor:
Cairo University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
25-40 years
Phase:
NA
Brief Summary
This study will be carried out in an attempt to know which is more effective, Intermittent fasting diet or resistive exercise program on insulin resistance in obese woman with polycystic ovarian syndr...
Detailed Description
Polycystic ovarian syndrome (PCOS) significantly impacts women, since the broad spectrum of clinical manifestations associated with it are significant and include reproductive dysfunction, menstrual i...
Eligibility Criteria
Inclusion
- Seventy two obese women diagnosed with Polycystic ovarian syndrome by the gynecologist (based on the Rotterdam diagnostic criteria)
- Their age will range from 25 to 40 years old.
- Overweight or obese (BMI \>25 kg/m2 and \< 30 kg/m2).
Exclusion
- The presence of diseases (such as congenital adrenal hyperplasia, Cushing syndrome, androgen secreting tumors, hyperprolactinemia, diabetes, thyroid diseases, Severe serious cardiovascular, gastrointestinal, kidney and liver diseases. premature ovarian failure, hypothalamic/pituitary disease
- Hormonal contraceptive use.
- Participants who did not complete the study were excluded from the analysis.
- Use of medication therapy that impacts carbohydrate or lipid metabolism (oral contraceptive pills, insulin sensitizers, anti epileptics, anti psychotics, statins, and fish oil) in the recent 6 months;
- Body weight fluctuations for more than 5% in the past 3 months; in preparation for pregnancy.
- Perimenopausal; night shift workers; fasting for more than 16 h per day; hypotension
- Alcohol intake for more than 100 g per week; smoking within the past 3 months
- Engaging in high intensity exercise.
Key Trial Info
Start Date :
March 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06882291
Start Date
March 20 2025
End Date
September 30 2025
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mashtoul Elsouq general Hospital
‘Ezbet el-Sharika el-Miṣrîya, Egypt